These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35954390)
21. In-depth single-cell and bulk-RNA sequencing developed a NETosis-related gene signature affects non-small-cell lung cancer prognosis and tumor microenvironment: results from over 3,000 patients. Zhang L; Zhang X; Guan M; Yu F; Lai F Front Oncol; 2023; 13():1282335. PubMed ID: 37927467 [TBL] [Abstract][Full Text] [Related]
22. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
23. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
24. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
25. Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma. Zhang Z; Pan J; Cheng D; Shi Y; Wang L; Mi Z; Fu J; Tao H; Fan H Front Genet; 2022; 13():965126. PubMed ID: 36092937 [No Abstract] [Full Text] [Related]
26. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449 [TBL] [Abstract][Full Text] [Related]
27. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression. Wang M; Zhu J; Zhao F; Xiao J Front Oncol; 2021; 11():643503. PubMed ID: 34595103 [TBL] [Abstract][Full Text] [Related]
28. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
29. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma. Niu W; Jiang L Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527 [TBL] [Abstract][Full Text] [Related]
30. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971 [TBL] [Abstract][Full Text] [Related]
31. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
32. Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA. Tian C; Guo H; Wei W J Oncol; 2023; 2023():2353249. PubMed ID: 36816364 [TBL] [Abstract][Full Text] [Related]
33. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma. Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758 [TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
35. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
36. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma. Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245 [TBL] [Abstract][Full Text] [Related]
37. Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma. Li Z; Ma Z; Xue H; Shen R; Qin K; Zhang Y; Zheng X; Zhang G Front Genet; 2022; 13():917150. PubMed ID: 35873497 [No Abstract] [Full Text] [Related]
38. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
39. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures. Lu F; Gao J; Hou Y; Cao K; Xia Y; Chen Z; Yu H; Chang L; Li W Front Oncol; 2022; 12():876360. PubMed ID: 35785179 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma. Tan Z; Lei Y; Zhang B; Shi S; Liu J; Yu X; Xu J; Liang C Front Oncol; 2021; 11():674897. PubMed ID: 34367961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]